Everything below concerns deamidation. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-07-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Free base form |
| Molecular mass | Approximately 4813 Da | Calculated from the sequence |
| Amino acid residues | 39 | GIP-derived backbone |
| Receptor targets | GIP and GLP-1 | Dual agonist |
| Circulating half-life | About 5 days | Supports weekly administration |
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
Lyophilized material is generally held at -20 degrees Celsius or lower, desiccated and protected from light, where it remains stable for extended periods. Reconstituted or ready-to-use solution is usually kept at 2 to 8 degrees Celsius with minimal agitation. Repeated freeze-thaw cycles should be avoided because they promote aggregation and reduce the soluble monomer fraction. Shipment of frozen solid commonly uses dry ice, while refrigerated liquid moves with validated cold packs. Stability beyond documented periods is not established.
Characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity and related-substance profiling, with ultraviolet detection near 214 nanometers. Mass spectrometry confirms molecular mass and reveals modifications such as oxidation or deamidation. Peptide mapping after enzymatic digestion verifies the amino acid sequence, while amino acid analysis supplies compositional data. Circular dichroism and infrared spectroscopy are used to assess secondary structure, particularly the alpha-helical content that influences aggregation behavior in solution.
== In popular culture == In Jules Verne's 1870 novel, 20,000 Leagues Under The Sea, the story is written in the form of narration from journal entries by Professor Pierre Aronnax, a naturalist from the Paris Museum of Natural History (the name of the museum at the time). The Gallery of Palaeontology and Comparative Anatomy and other parts of Jardin des Plantes was a source of inspiration for French graphic novelist Jacques Tardi. The gallery appears on the first page and several subsequent pages of Adèle et la bête (Adèle and the Beast; 1976), the first album in the series of Les Aventures extraordinaires d'Adèle Blanc-Sec. The story opens with a 136-million-year-old pterodactyl egg hatching, and a live pterodactyl escaping through the gallery glass roof, wreaking havoc and killing people in Paris. The Gallery of Palaeontology and Comparative Anatomy returned the favour by placing a life size cardboard cutout of Adèle and the hatching pterodactyl in a glass cabinet outside the main entrance on the top floor balcony. The Pulitzer Prize–winning novel All the Light We Cannot See, by Anthony Doerr, partially takes place at the MNHN; the father of the protagonist Marie-Laure works as the chief locksmith of the museum. The story also makes many references to Jules Verne's novel 20,000 Leagues Under the Seas, and the fictional naturalist and narrator Professor Pierre Aronnax. Marie-Laure was gifted braille books of the novel by her father.
Jess A. Cliffe (born June 27, 1981) is a video game designer who co-created the Half-Life mod Counter-Strike with Minh Le and started the Counter-Strike series. In the first entry of the series, he is the voice of the radio commands, the voiceline "Counter-Terrorists Win!" and various sound effects. He has worked on maps for Half-Life: Deathmatch.
== Applications == Synthetic biology initiatives frequently aim to redesign organisms so that they can create a material, such as a drug or fuel, or acquire a new function, such as the ability to sense something in the environment. Examples of what researchers are creating using synthetic biology include:
=== In the broader sense === In food and industrial contexts, any chemical modification performed by a living being in a controlled container can be termed "fermentation". The following do not fall into the biochemical sense, but are called fermentation in the larger sense:
== See also == Bond number – Dimensionless number in fluid dynamicsPages displaying short descriptions of redirect targets Bound water – Thin layer of water surrounding mineral surfaces Capillary action through synthetic mesh Capillary fringe – Subsurface layer in which groundwater seeps up from a water table by capillary action Capillary pressure – Pressure between two fluids from forces between the fluids and tube walls Capillary wave – Wave on the surface of a fluid, dominated by surface tension Capillary bridges – Minimised surface of liquid connecting two wetted objectsPages displaying short descriptions of redirect targets Damp proofing – Type of moisture control in building construction Darcy's law – Equation describing the flow of a fluid through a porous medium Frost flower – Thin layer of ice extruded from a plant Frost heaving – Upwards swelling of soil during freezing Hindu milk miracle – 1995 alleged miracle incidentsPages displaying short descriptions of redirect targets Krogh model Porosimetry – Measurement and characterization of the porosity of a material Needle ice – Ice column formed when liquid groundwater rises into freezing air Surface tension – Tendency of a liquid surface to shrink to reduce surface area Washburn's equation – Equation describing the penetration length of a liquid into a capillary tube with time Young–Laplace equation – Describing pressure difference over an interface in fluid mechanics
Sources: en.wikipedia.org
==== ACTH and GH release ==== TRH promotes release growth hormone (GH) in individuals with certain pathological conditions, and of adrenocorticotropic hormone (ACTH) in some individuals with Cushing's disease. TRH promotes GH release in individuals with acromegaly; prolonged exposure to GHRH may cause the pituitary to release GH in response to TRH. TRH may also promote GH release in individuals with hepatic disease, uremia, childhood hypothyroidism, anorexia nervosa, and depression. Conversely, TRH suppresses GH release during sleep.
==== Federal drug schedule system introduced ==== The Richard Nixon presidency (1969–74) incorporated his predecessor's anti-drug initiative in a tough-on-crime platform. In his 1968 presidential nomination acceptance speech, Nixon promised, "Our new Attorney General will ... launch a war against organized crime in this country. ... will be an active belligerent against the loan sharks and the numbers racketeers that rob the urban poor. ... will open a new front against the filth peddlers and the narcotics peddlers who are corrupting the lives of the children of this country." In a 1969 special message to Congress, he identified drug abuse as "a serious national threat". On October 27, 1970, Nixon signed into law the Comprehensive Drug Abuse Prevention and Control Act of 1970, establishing his approach to drug control. The act largely repealed mandatory minimum sentences: simple possession was reduced from a felony to a misdemeanor, the first offense carried a maximum of one year in prison, and judges had the latitude to assign probation, parole or dismissal. Penalties for trafficking were increased, up to life depending on the quantity and type of drug. Funding was authorized for the Department of Health, Education and Welfare to provide treatment, rehabilitation and education. Additional federal drug agents were provided, and a "no-knock" power was instituted, that allowed entry into homes without warning to prevent evidence from being destroyed. Licensing and stricter reporting and record-keeping for pharmaceutical manufacturers and distributors occurred under the act.
== External links == Atrial+Natriuretic+Factor at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Human NPPA genome location and NPPA gene details page in the UCSC Genome Browser. Overview of all the structural information available in the PDB for UniProt: P01160 (Natriuretic peptides A) at the PDBe-KB.
Spondyloepiphyseal dysplasia congenita is one of a spectrum of skeletal disorders caused by mutations in the COL2A1 gene. The protein made by this gene forms type II collagen, a molecule found mostly in cartilage and in the clear gel that fills the eyeball (the vitreous). Type II collagen is essential for the normal development of bones and other connective tissues. Mutations in the COL2A1 gene interfere with the assembly of type II collagen molecules, which prevents bones from developing properly and causes the signs and symptoms of this condition. Spondyloepiphyseal dysplasia congenita is inherited in an autosomal dominant pattern, which means one copy of the altered gene is sufficient to cause the disorder.
By that time, BMS had already withdrawn the drug from the market in Europe, Australia, New Zealand, and Canada. In August 2020, Teva Pharmaceuticals placed nefazodone in shortage due to a shortage of a raw ingredient. On December 20, 2021, nefazodone was again made available in all strengths.
Sources: en.wikipedia.org
== Working class history == Detlev Peukert was born in Gütersloh, Eastern Westphalia, the son of Konrad Peukert, a mining engineer from Oederan/Flöha (Saxony), and his wife Ilse (Kramer) Peukert, a secretary from Gütersloh. He grew up in Hamm-Herringen in the Ruhr area. Many of his father's fellow coal miners had been members of either the SPD or KPD, and were sent to concentration camps during the Nazi era. Growing up in the coal miners' milieu, where many so had been sent to concentration camps for anti-Nazi views, left Peukert very interested in the subject of outsiders in the Third Reich, as he wanted to know why so many coal miners chose to oppose the Nazi regime when so many other ordinary people were passive, indifferent or supportive of the Nazi regime. The coal miners of the Ruhr formed a distinctive sub-culture in Germany, known for their defiant, rebellious attitude to authority, left-wing views, and their often confrontational relations with the firm of Krupp AG, Germany's biggest corporation, which in turn was owned by the Krupp family, Germany's richest family. As a student, Peukert studied under Hans Mommsen at Bochum university, and began teaching at the University of Essen starting in 1978. As a "68er" whose politics were defined by the student protests of 1968, Peukert was active in left-wing politics and joined the German Communist Party (DKP).
== Prevention == Key prevention strategies for cirrhosis are population-wide interventions to reduce alcohol intake (through pricing strategies, public health campaigns, and personal counseling), programs to reduce the transmission of viral hepatitis, and screening of relatives of people with hereditary liver diseases. Little is known about factors affecting cirrhosis risk and progression. However, many studies have provided increasing evidence for the protective effects of coffee consumption against the progression of liver disease. These effects are more noticeable in liver disease that is associated with alcohol use disorder. Coffee has antioxidant and antifibrotic effects. Caffeine may not be the important component; polyphenols may be more important. Drinking two or more cups of coffee a day is associated with improvements in the liver enzymes ALT, AST, and GGT. Even in those with liver disease, coffee consumption can lower fibrosis and cirrhosis.
Riboflavin, also known as vitamin B2, is a vitamin found in food and sold as a dietary supplement. It is essential to the formation of two major coenzymes, flavin mononucleotide and flavin adenine dinucleotide. These coenzymes are involved in energy metabolism, cellular respiration, and antibody production, as well as normal growth and development. The coenzymes are also required for the metabolism of niacin, vitamin B6, and folate. Riboflavin is prescribed to treat corneal thinning, and taken orally, may reduce the incidence of migraine headaches in adults. Riboflavin deficiency is rare and is usually accompanied by deficiencies of other vitamins and nutrients. It may be prevented or treated by oral supplements or by injections. As a water-soluble vitamin, any riboflavin consumed in excess of nutritional requirements is not stored; it is either not absorbed or is absorbed and quickly excreted in urine, causing the urine to have a bright yellow tint. Natural sources of riboflavin include meat, fish and fowl, eggs, dairy products, green vegetables, mushrooms, and almonds. Some countries require its addition to grains. In its purified, solid form, it is a water-soluble yellow-orange crystalline powder. In addition to its function as a vitamin, it is used as a food coloring agent. Biosynthesis takes place in bacteria, fungi and plants, but not animals. Industrial synthesis of riboflavin was initially achieved using a chemical process, but current commercial manufacturing relies on fermentation methods using strains of fungi and genetically modified bacteria.
== Surgical procedure == TOPS is implanted following a lumbar decompression, in which bone and ligament tissue compressing the spinal nerves are removed. After decompression, the facet joints are excised and replaced with the TOPS implant. The goal is to preserve mobility at the treated level while preventing instability that would otherwise be addressed with spinal fusion.
"One strain isolated from tissue debrided from a compound fracture of the tibia was particularly active. We named this growth-antagonistic strain for the patient, Tracy I. When cell-free filtrates of broth cultures of this bacillus proved to possess strong antibiotic activity and to be non-toxic, further study seemed warranted. We have called this active principle 'bacitracin'." Bacitracin was approved by the US FDA in 1948.
Sources: en.wikipedia.org
It acts as a dual agonist at the GIP receptor and the GLP-1 receptor. This broader targeting profile distinguishes it from selective GLP-1 agonists, which engage only one receptor.
A fatty diacid side chain promotes binding to albumin, which delays clearance from circulation. The half-life of roughly five days makes a weekly schedule practical.
No. It is a synthetic peptide whose backbone is based on the natural incretin hormone GIP. Non-natural residues and the lipid side chain were engineered to improve stability and duration of action.
It activates both GIP and GLP-1 receptors. This dual action differentiates it from selective GLP-1 agonists.